Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Emeritus Professor Philip Home

Newcastle AuthorsTitleYearFull text
Emeritus Professor Philip Home
How Valid Are the New Hypoglycemia Definitions for Use in Clinical Trials?2020
Emeritus Professor Philip Home
Hypoglycaemia risk with insulin glargine 300 U/mL compared with glargine 100 U/mL across different baseline fasting C-peptide levels in insulin-naïve people with type 2 diabetes: A post hoc analysis of the EDITION 3 trial2020
Emeritus Professor Philip Home
Impact of a weekly glucagon-like peptide 1 receptor agonist, albiglutide, on glycemic control and on reducing prandial insulin use in type 2 diabetes inadequately controlled on multiple insulin therapy: A randomized trial2020
Emeritus Professor Philip Home
Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) compared with premix or addition of meal-time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta-analysis2020
Emeritus Professor Philip Home
Is Insulin Therapy Safe?2020
Emeritus Professor Philip Home
Tackling obesity during the COVID-19 pandemic2020
Emeritus Professor Philip Home
Cardiovascular outcome trials of glucose-lowering medications: an update2019
Emeritus Professor Philip Home
Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%2019
Emeritus Professor Philip Home
Controversies for Glucose Control Targets in Type 2 Diabetes: Exposing the Common Ground2019
Emeritus Professor Philip Home
Determination of fasiglifam-induced liver toxicity: Insights from the data monitoring committee of the fasiglifam clinical trials program2019
1234567891011121314151617181920...